GlassScriptPhysician profile
Prit Sinchai
NPI 1528191269
$1,260.47
in general payments reported to CMS, 2019-2025
22 companies · $79.96 in 2025
The $79.96 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $550 · 2020: $509 · 2021: $23.74 · 2022: $46.93 · 2024: $50.31 · 2025: $79.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $130.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $417.45 | 2019-2020 | |
| Optos, INC. | $157.84 | 2019 | |
| Rxsight INC | $81.64 | 2022-2025 | Rxsight Injector Cartridge, Light Adjustable Lens (Lal), Rxsight Contact Lens |
| Aerie Pharmaceuticals, INC. | $75.17 | 2019-2020 | |
| Shire North American Group INC | $73.45 | 2019 | |
| Alcon Vision LLC | $59.83 | 2019-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $39.12 | 2019 | |
| Lensar, INC. | $37.62 | 2019-2025 | Lensar Laser System |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $35.98 | 2019-2020 | |
| Glaukos Corporation | $33.66 | 2024 | Istent Trabecular Micro-Bypass System Model Is3 |
| Sun Pharmaceutical Industries INC. | $30.62 | 2020 | |
| Eyevance Pharmaceuticals LLC | $27.89 | 2020 | |
| Sight Sciences, INC. | $26.37 | 2025 | Omni Surgical System |
| Coopervision INC. | $23.46 | 2019 | |
| Horizon Therapeutics Plc | $22.18 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $21.98 | 2020 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Bausch & Lomb Americas INC. | $18.82 | 2022 | |
| Alcon Research LLC | $17.57 | 2019 | |
| Novartis Pharmaceuticals Corporation | $15.43 | 2019 | |
| Akorn, INC. | $12.79 | 2020 | |
| Oasis Medical, INC. | $12.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prit Sinchai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.